Clinical Trial Update: Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status [Phase 2, Phase 3]

View source ↗

Summary

An exploratory Phase 2/3 clinical trial evaluating combined conversion immunotherapy for liver metastases from unresectable MSS-type colorectal cancer, based on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Colorectal Cancer, Liver Metastases | Phase 2, Phase 3 | Status: UNKNOWN